Breast Cancer Morbidity

Treatment Related Morbidity in Breast Cancer Patients

In a prospective study, long term upper-limb morbidity, perceived disabilities in activities of daily life (ADL) and quality of life (QOL) were assessed before, at one year and two years after sentinel lymph node biopsy (SLNB) or axillary lymph node dissections (ALND) for breast cancer. Considerable treatment related upper-limb morbidity was observed. Significant (p<0.05) changes between before...

Psychiatric morbidity after screening for breast cancer.

One hundred and thirty two women with normal breast screening results were interviewed six months after their attendance at the Edinburgh Breast Screening Clinic. Eight percent of women said screening had made them more anxious about developing breast cancer. Thirty eight percent said they were more aware of the disease since screening but they regarded this as advantageous. Seventy percent of ...

Arm morbidity after breast-conserving therapy for breast cancer.

This study reports on 110 consecutive patients, mean age 59 years, operated on for partial mastectomy and axillary dissection. Radiotherapy of 50 Gy was administered to 75 of the patients. Most tumours were T1 tumours and all patients were NO. Lymphoedema is defined as an increase in arm volume > 10% and impaired shoulder mobility as an impairment of 15 degrees compared with the preoperative va...

Breast Implants and Breast Cancer

Locoregional therapy of breast cancer: maximizing control, minimizing morbidity.

The goal of locoregional therapy in breast cancer has remained unchanged for a century: the eradication of all malignant cells from the breast and draining lymph nodes, hopefully prior to them having spread to distant organs. However, how we accomplish this goal has changed dramatically over this time period and our success in achieving this goal has been greatly enhanced by improvements in bre...